Global Ankylosing Spondylitis Drug Market Size, Status and Forecast 2021-2027

Global Ankylosing Spondylitis Drug Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cimzia
1.2.3 Enbrel
1.2.4 Humira
1.2.5 Remicade
1.2.6 Simponi
1.2.7 Others
1.3 Market by Application
1.3.1 Global Ankylosing Spondylitis Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ankylosing Spondylitis Drug Market Perspective (2016-2027)
2.2 Ankylosing Spondylitis Drug Growth Trends by Regions
2.2.1 Ankylosing Spondylitis Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ankylosing Spondylitis Drug Historic Market Share by Regions (2016-2021)
2.2.3 Ankylosing Spondylitis Drug Forecasted Market Size by Regions (2022-2027)
2.3 Ankylosing Spondylitis Drug Industry Dynamic
2.3.1 Ankylosing Spondylitis Drug Market Trends
2.3.2 Ankylosing Spondylitis Drug Market Drivers
2.3.3 Ankylosing Spondylitis Drug Market Challenges
2.3.4 Ankylosing Spondylitis Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ankylosing Spondylitis Drug Players by Revenue
3.1.1 Global Top Ankylosing Spondylitis Drug Players by Revenue (2016-2021)
3.1.2 Global Ankylosing Spondylitis Drug Revenue Market Share by Players (2016-2021)
3.2 Global Ankylosing Spondylitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ankylosing Spondylitis Drug Revenue
3.4 Global Ankylosing Spondylitis Drug Market Concentration Ratio
3.4.1 Global Ankylosing Spondylitis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ankylosing Spondylitis Drug Revenue in 2020
3.5 Ankylosing Spondylitis Drug Key Players Head office and Area Served
3.6 Key Players Ankylosing Spondylitis Drug Product Solution and Service
3.7 Date of Enter into Ankylosing Spondylitis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ankylosing Spondylitis Drug Breakdown Data by Type
4.1 Global Ankylosing Spondylitis Drug Historic Market Size by Type (2016-2021)
4.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Type (2022-2027)
5 Ankylosing Spondylitis Drug Breakdown Data by Application
5.1 Global Ankylosing Spondylitis Drug Historic Market Size by Application (2016-2021)
5.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Ankylosing Spondylitis Drug Market Size (2016-2027)
6.2 North America Ankylosing Spondylitis Drug Market Size by Type
6.2.1 North America Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
6.2.2 North America Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
6.2.3 North America Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
6.3 North America Ankylosing Spondylitis Drug Market Size by Application
6.3.1 North America Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
6.3.2 North America Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
6.3.3 North America Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
6.4 North America Ankylosing Spondylitis Drug Market Size by Country
6.4.1 North America Ankylosing Spondylitis Drug Market Size by Country (2016-2021)
6.4.2 North America Ankylosing Spondylitis Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Ankylosing Spondylitis Drug Market Size (2016-2027)
7.2 Europe Ankylosing Spondylitis Drug Market Size by Type
7.2.1 Europe Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
7.2.2 Europe Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
7.2.3 Europe Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
7.3 Europe Ankylosing Spondylitis Drug Market Size by Application
7.3.1 Europe Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
7.3.2 Europe Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
7.3.3 Europe Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
7.4 Europe Ankylosing Spondylitis Drug Market Size by Country
7.4.1 Europe Ankylosing Spondylitis Drug Market Size by Country (2016-2021)
7.4.2 Europe Ankylosing Spondylitis Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size (2016-2027)
8.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type
8.2.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application
8.3.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region
8.4.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Ankylosing Spondylitis Drug Market Size (2016-2027)
9.2 Latin America Ankylosing Spondylitis Drug Market Size by Type
9.2.1 Latin America Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
9.2.2 Latin America Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
9.2.3 Latin America Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
9.3 Latin America Ankylosing Spondylitis Drug Market Size by Application
9.3.1 Latin America Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
9.3.2 Latin America Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
9.3.3 Latin America Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
9.4 Latin America Ankylosing Spondylitis Drug Market Size by Country
9.4.1 Latin America Ankylosing Spondylitis Drug Market Size by Country (2016-2021)
9.4.2 Latin America Ankylosing Spondylitis Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size (2016-2027)
10.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type
10.2.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application
10.3.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country
10.4.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Ankylosing Spondylitis Drug Introduction
11.1.4 Amgen Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Wyeth
11.2.1 Wyeth Company Details
11.2.2 Wyeth Business Overview
11.2.3 Wyeth Ankylosing Spondylitis Drug Introduction
11.2.4 Wyeth Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.2.5 Wyeth Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Ankylosing Spondylitis Drug Introduction
11.3.4 Takeda Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.3.5 Takeda Recent Development
11.4 Centocor
11.4.1 Centocor Company Details
11.4.2 Centocor Business Overview
11.4.3 Centocor Ankylosing Spondylitis Drug Introduction
11.4.4 Centocor Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.4.5 Centocor Recent Development
11.5 Schering-Plough
11.5.1 Schering-Plough Company Details
11.5.2 Schering-Plough Business Overview
11.5.3 Schering-Plough Ankylosing Spondylitis Drug Introduction
11.5.4 Schering-Plough Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.5.5 Schering-Plough Recent Development
11.6 Mitsubishi Tanabe
11.6.1 Mitsubishi Tanabe Company Details
11.6.2 Mitsubishi Tanabe Business Overview
11.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Introduction
11.6.4 Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.6.5 Mitsubishi Tanabe Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Ankylosing Spondylitis Drug Introduction
11.7.4 Abbott Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.7.5 Abbott Recent Development
11.8 Eisai
11.8.1 Eisai Company Details
11.8.2 Eisai Business Overview
11.8.3 Eisai Ankylosing Spondylitis Drug Introduction
11.8.4 Eisai Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.8.5 Eisai Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Ankylosing Spondylitis Drug Introduction
11.9.4 Pfizer Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Introduction
11.10.4 Johnson & Johnson Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cimzia
Table 3. Key Players of Enbrel
Table 4. Key Players of Humira
Table 5. Key Players of Remicade
Table 6. Key Players of Simponi
Table 7. Key Players of Others
Table 8. Global Ankylosing Spondylitis Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Ankylosing Spondylitis Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Ankylosing Spondylitis Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Ankylosing Spondylitis Drug Market Share by Regions (2016-2021)
Table 12. Global Ankylosing Spondylitis Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Ankylosing Spondylitis Drug Market Share by Regions (2022-2027)
Table 14. Ankylosing Spondylitis Drug Market Trends
Table 15. Ankylosing Spondylitis Drug Market Drivers
Table 16. Ankylosing Spondylitis Drug Market Challenges
Table 17. Ankylosing Spondylitis Drug Market Restraints
Table 18. Global Ankylosing Spondylitis Drug Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Ankylosing Spondylitis Drug Market Share by Players (2016-2021)
Table 20. Global Top Ankylosing Spondylitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ankylosing Spondylitis Drug as of 2020)
Table 21. Ranking of Global Top Ankylosing Spondylitis Drug Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Ankylosing Spondylitis Drug Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Ankylosing Spondylitis Drug Product Solution and Service
Table 25. Date of Enter into Ankylosing Spondylitis Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2016-2021)
Table 29. Global Ankylosing Spondylitis Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Ankylosing Spondylitis Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Ankylosing Spondylitis Drug Revenue Market Share by Application (2016-2021)
Table 33. Global Ankylosing Spondylitis Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Ankylosing Spondylitis Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Ankylosing Spondylitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Ankylosing Spondylitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Ankylosing Spondylitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Ankylosing Spondylitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Ankylosing Spondylitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Ankylosing Spondylitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 65. Amgen Company Details
Table 66. Amgen Business Overview
Table 67. Amgen Ankylosing Spondylitis Drug Product
Table 68. Amgen Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 69. Amgen Recent Development
Table 70. Wyeth Company Details
Table 71. Wyeth Business Overview
Table 72. Wyeth Ankylosing Spondylitis Drug Product
Table 73. Wyeth Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 74. Wyeth Recent Development
Table 75. Takeda Company Details
Table 76. Takeda Business Overview
Table 77. Takeda Ankylosing Spondylitis Drug Product
Table 78. Takeda Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 79. Takeda Recent Development
Table 80. Centocor Company Details
Table 81. Centocor Business Overview
Table 82. Centocor Ankylosing Spondylitis Drug Product
Table 83. Centocor Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 84. Centocor Recent Development
Table 85. Schering-Plough Company Details
Table 86. Schering-Plough Business Overview
Table 87. Schering-Plough Ankylosing Spondylitis Drug Product
Table 88. Schering-Plough Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 89. Schering-Plough Recent Development
Table 90. Mitsubishi Tanabe Company Details
Table 91. Mitsubishi Tanabe Business Overview
Table 92. Mitsubishi Tanabe Ankylosing Spondylitis Drug Product
Table 93. Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 94. Mitsubishi Tanabe Recent Development
Table 95. Abbott Company Details
Table 96. Abbott Business Overview
Table 97. Abbott Ankylosing Spondylitis Drug Product
Table 98. Abbott Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 99. Abbott Recent Development
Table 100. Eisai Company Details
Table 101. Eisai Business Overview
Table 102. Eisai Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 103. Eisai Recent Development
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Ankylosing Spondylitis Drug Product
Table 107. Pfizer Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 108. Pfizer Recent Development
Table 109. Johnson & Johnson Company Details
Table 110. Johnson & Johnson Business Overview
Table 111. Johnson & Johnson Ankylosing Spondylitis Drug Product
Table 112. Johnson & Johnson Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
Table 113. Johnson & Johnson Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ankylosing Spondylitis Drug Market Share by Type: 2020 VS 2027
Figure 2. Cimzia Features
Figure 3. Enbrel Features
Figure 4. Humira Features
Figure 5. Remicade Features
Figure 6. Simponi Features
Figure 7. Others Features
Figure 8. Global Ankylosing Spondylitis Drug Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Ankylosing Spondylitis Drug Report Years Considered
Figure 12. Global Ankylosing Spondylitis Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Ankylosing Spondylitis Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Ankylosing Spondylitis Drug Market Share by Regions: 2020 VS 2027
Figure 15. Global Ankylosing Spondylitis Drug Market Share by Regions (2022-2027)
Figure 16. Global Ankylosing Spondylitis Drug Market Share by Players in 2020
Figure 17. Global Top Ankylosing Spondylitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ankylosing Spondylitis Drug as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Ankylosing Spondylitis Drug Revenue in 2020
Figure 19. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2016-2021)
Figure 20. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2022-2027)
Figure 21. North America Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
Figure 23. North America Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
Figure 24. North America Ankylosing Spondylitis Drug Market Share by Country (2016-2027)
Figure 25. United States Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
Figure 29. Europe Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
Figure 30. Europe Ankylosing Spondylitis Drug Market Share by Country (2016-2027)
Figure 31. Germany Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Ankylosing Spondylitis Drug Market Share by Region (2016-2027)
Figure 41. China Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
Figure 49. Latin America Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
Figure 50. Latin America Ankylosing Spondylitis Drug Market Share by Country (2016-2027)
Figure 51. Mexico Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Ankylosing Spondylitis Drug Market Share by Country (2016-2027)
Figure 57. Turkey Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 61. Wyeth Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 62. Takeda Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 63. Centocor Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 64. Schering-Plough Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 65. Mitsubishi Tanabe Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 66. Abbott Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 67. Eisai Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs